• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Geriatric Use Supplement Safety/Adverse Reaction Category

FDA Data Element Number.

CDER Data Element Number. C-DRG-00916

Version Number. 001

Data Element Name. Geriatric Use Supplement Safety/Adverse Reaction Category

Description. Geriatric Use Supplement Safety/Adverse Reaction Category describes the safety and adverse reaction categories that are applicable to CDER Geriatric Use Supplements.

Source. Form FDA 3437.

Relationship.

FDA Specifications.

CDER Specifications. Geriatric Use Supplement Safety/Adverse Reaction Category shall consist of an alphanumeric term which has a maximum length restricted to 240 characters, and a corresponding alphanumeric code with a maximum length of 3 characters. (Reference table column_id = ger_use_sup_safety)

FDA Approved Date.

CDER Approved Date. February 1, 2000

FDA Revised Date.

CDER Revised Date.

Data Values.

NAME DEFINITION FDA CODE
CLINICAL EFFICACY TRIALS, RAW DATA AND STUDY ANALYSIS Literal CR
CLINICAL EFFICACY TRIALS, LITERATURE Literal CL
ANECDOTAL REPORTS, MEDWATCH / FORM 3500 Literal AM
ANECDOTAL REPORTS, LITERATURE Literal AL